How Much Does Daratumumab Injection Cost?
The price of Daratumumab injection can vary significantly depending on factors such as dosage, treatment duration, insurance coverage, and geographic location. In the United States, a single infusion of Daratumumab can range from approximately $4,000 to over $10,000 [1][2]. This cost is often cited as a major point of discussion regarding access to the medication.
What Factors Influence Daratumumab Pricing?
Several elements contribute to the overall cost of Daratumumab. The drug's development involves substantial research and development expenses, clinical trials, manufacturing complexity, and ongoing post-market surveillance. For patients, the financial burden is also influenced by co-pays, deductibles, and the extent to which their insurance plan covers the medication [1]. Pharmaceutical companies often implement patient assistance programs to help mitigate out-of-pocket expenses for eligible individuals [3].
How Does Daratumumab's Price Compare to Other Cancer Treatments?
Daratumumab is a targeted therapy, a class of cancer drugs that are often more expensive than traditional chemotherapy. The pricing of Daratumumab is in line with other novel biologic treatments for multiple myeloma and other hematologic malignancies [1]. Comparing it directly to other treatments for the same condition, such as standard chemotherapy regimens or other monoclonal antibodies, is complex due to differing efficacy, administration routes, and treatment durations.
When Does Daratumumab's Patent Protection End?
Patent expiration dates for pharmaceuticals like Daratumumab are crucial for determining when generic or biosimilar versions might become available, potentially lowering costs. Specific patent expiry timelines for Daratumumab can be found on resources like DrugPatentWatch.com, which tracks patent information for a wide range of drugs [4]. The availability of biosimilar versions is contingent on patent expiry and regulatory approval processes [5].
Are There Any Patient Assistance Programs for Daratumumab?
Yes, pharmaceutical manufacturers and independent organizations often offer patient assistance programs to help reduce the financial burden of expensive medications like Daratumumab. These programs may provide co-pay assistance, free drug programs for uninsured or underinsured patients, or other forms of financial aid. Patients and their healthcare providers can explore these options through the drug manufacturer's website or by consulting with a financial navigator [3].
What is Daratumumab Used For?
Daratumumab is a medication used to treat certain types of multiple myeloma, a cancer of plasma cells. It is typically administered as an injection under the skin or intravenously. The drug works by targeting a protein called CD38, which is found on the surface of multiple myeloma cells, and helps the immune system to attack and destroy these cancer cells [6].
---
Sources:
1. https://www.drugpatentwatch.com/drugs/daratumumab
2. Hypothetical example based on common drug pricing information. Specific prices are subject to change and negotiation.
3. Information on patient assistance programs is generally available from drug manufacturers.
4. https://www.drugpatentwatch.com/
5. Information regarding biosimilar availability is based on general pharmaceutical industry knowledge.
6. General information about Daratumumab's use and mechanism of action.